Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese

Journal of Molecular Neuroscience

Volumn 34, Issue 3, 2008, Pages 235-240

  Bian, Jian Tao ^a   Zhao, Hua Lu ^a   Zhang, Zhen Xin ^b   Bi, Xiu Hua ^a   Zhang, Jun Wu ^a,c  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Alzheimer's disease; Apolipoprotein E; Chinese; Gene polymorphisms; NAD(P)H:quinone oxidoreductase 1 (NQO1)

Indexed keywords

OXIDOREDUCTASE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE:QUINONE OXIDOREDUCTASE 1; APOLIPOPROTEIN E4; NQO1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; AGED; ALZHEIMER DISEASE; APOE EPSILON4 GENE; ARTICLE; CHINESE; CONTROLLED STUDY; ENZYME MECHANISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NQO1 GENE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RISK FACTOR; ASIAN; BRAIN; BRAIN LEVEL; CASE CONTROL STUDY; CELL PROTECTION; CHINA; ENZYMOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CHINA; CYTOPROTECTION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; POLYMORPHISM, GENETIC;

EID: 45549108078     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9036-z     Document Type: Article

References (34)

1. Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica (Berl), 82, 239-259.
2. Butterfield, D. A., Hensley, K., Hall, N., et al. (1996). b-Amyloid-derived free radical oxidation: A fundamental process in Alzheimer's disease. In W. Wasco, & R. E. Tanzi (Eds.) Molecular Models of Dementia (pp. 145-167). Totowa, NJ, USA: Humana.
3. Chesis, P. L., Levin, D. E., Smith, M. T., Ernster, L., & Ames, B. N. (1984). Mutagenicity of quinones: Pathways of metabolic activation and detoxification. Proceedings of the National Academy of Sciences of the United States of America, 81, 1696-1700.
4. Clairmont, A., Sies, H., Ramachandran, S., et al. (1990). Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis, 20, 1235-1240.
5. Combarros, O., Infante, J., Llorca, J., & Berciano, J. (2004). Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 18, 55-58.
6. Ernster, L. (1967). DT-diaphorase. Methods in Enzymology, 10, 309-317.
7. Ernster, L., & Navazio, F. (1958). Soluble diaphorase in animal tissues. Acta Chemica Scandinavica, 2, 595-602.
8. Gatz, M., Pedersen, N. L., Berg, S., et al. (1997). Heritability for Alzheimer's disease: The study of dementia in Swedish twins. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 52, M117-125.
9. Goto, Y., Hamajima, N., Honda, H., et al. (2005). Association between Helicobacter pylori seropositivity and NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism observed in outpatients and health checkup examinees. Gastric Cancer, 8, 12-17.
10. Huggins, C. B., Ueda, N., & Russo, A. (1978). Azo dyes prevent hydrocarbon-induced leukemia in the rat. Proceedings of the National Academy of Sciences of the United States of America, 75, 4524-4527.
11. Infante-Rivard, C., Vermunt, J. K., & Weinberg, C. R. (2007). Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. American Journal of Epidemiology, 165, 1248-1254.
12. Kuehl, B. L., Paterson, J. W., Peacock, J. W., Paterson, M. C., & Rauth, A. M. (1995). Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. British Journal of Cancer, 72, 555-561.
13. Lafuente, M. J., Casterad, X., Trias, M., et al. (2000). NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis, 21, 1813-1819.
14. Lambert, M. P., Barlow, A. K., Chromy, B. A., et al. (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America, 95, 6448-6453.
15. Larson, R. A., Wang, Y., Banerjee, M., et al. (1999). Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood, 94, 803-807.
16. Lewis, S. J., Cherry, N. M., Niven, R. M., Barber, P. V., & Povey, A. C. (2001). Polymorphisms in the NAD(P)H:quinone oxidoreductase gene and small cell lung cancer risk in a UK population. Lung Cancer, 34, 177-183.
17. Ma, Q. L., Yang, J. F., Shao, M., Dong, X. M., & Chen, B. (2003). Association between NAD(P)H:quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease. Zhonghua Yi Xue Za Zhi, 83, 2124-2127 (in Chinese).
18. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
19. Moran, J. L., Siegel, D., & Roses, D. (1999). A potential mechanism underlying the in creased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proceedings of the National Academy of Sciences of the United States of America, 96, 8150-8155.
20. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1993). Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. Journal of Neuroscience, 13, 1676-1687.
21. Raina, A. K., Templeton, D. J., Deak, J. C., Perry, G., & Smith, M. A. (1999). Quinone reductase NQO1, a sensitive redox indicator, is increased in Alzheimer's disease. Redox Report, 4, 23-27.
22. Rauth, A. M., Goldberg, Z., & Misra, V. (1997). DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis. Oncology Research, 9, 339-349.
23. SantaCruz, K. S., Yazlovitskaya, E., Collins, J., Johnson, J., & DeCarli, C. (2004). Regional NAD(P)H:quinone noxidoreductase activity in Alzheimer's disease. Neurobiology of Aging, 5, 63-69.
24. Schulz, W. A., Krummeck, A., Rosinger, I., et al. (1997). Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics, 7, 235-239.
25. Smith, M. T. (1999). Benzene, NQO1, and genetic susceptibility to cancer. Proceedings of the National Academy of Sciences of the United States of America, 96, 7624-7626.
26. Stanulla, M., Dynybil, C., Bartels, D. B., Dördelmann, M., et al. (2007). The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: A matched-pair analysis from the ALL-BFM study group. Haematologica, 92, 1581-1582.
27. Strittmatter, W. J., & Roses, A. D. (1995). Apolipoprotein E and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 92, 4725-4727.
28. Terry, R. D. (1994). Neuropathological changes in Alzheimer disease. Progress in Brain Research, 101, 383-390.
29. Traver, R. D., Siegel, D., Beall, H. D., et al. (1997). Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase). British Journal of Cancer, 75, 69-75.
30. Wang, B. B., Jin, F., Xie, Y. C., et al. (2006). Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease. Neuroscience Letters, 409, 179-181.
31. Wang, Y., Santa-Cruz, K., DeCarli, C., & Johnson, J. A. (2000). NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. Neurobiology of Aging, 21, 525-531.
32. Wenham, P. R., Price, W. H., & Blandell, G. (1991). Apolipoprotein E genotyping by one-stage PCR. Lancet, 337, 1158-1159.
33. Wiemels, J. L., Pagnamenta, A., Taylor, G. M., Eden, O. B., Alexander, F. E., & Greaves, M. F. (1999). A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Research, 59, 4095-4099.
34. Yankner, B. A., & Mesulam, M. M. (1991). Seminars in medicine of the Beth Israel Hospital, Boston. Beta-amyloid and the pathogenesis of Alzheimer's disease. New England Journal of Medicine, 25, 1849-1857.